Works matching IS 03065251 AND DT 2019 AND VI 85 AND IP 6

Results: 37

Can cytidine deaminase be used as predictive biomarker for gemcitabine toxicity and response?

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1213, doi. 10.1111/bcp.13921

By:

Peters, Godefridus J.;
Giovannetti, Elisa;
Honeywell, Richard J.;
Ciccolini, Joseph

Publication type:

Article

Issue highlights.

Published in:: British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1047, doi. 10.1111/bcp.13978
Publication type:: Article

Reply to "Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!" by Stamp et al.

Published in:

2019

By:

Laville, Solène M.;
Stengel, Bénédicte;
Massy, Ziad A.;
Liabeuf, Sophie

Publication type:

Letter to the Editor

Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1367, doi. 10.1111/bcp.13908

By:

Clermont, Valérie;
Grangeon, Alexia;
Barama, Azemi;
Turgeon, Jacques;
Lallier, Michel;
Malaise, Jacques;
Michaud, Veronique

Publication type:

Article

Cetuximab pharmacokinetic/pharmacodynamics relationships in advanced head and neck carcinoma patients.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1357, doi. 10.1111/bcp.13907

By:

Le Louedec, Félicien;
Alix‐Panabières, Catherine;
Lafont, Thierry;
Allal, Ben C.;
Garrel, Renaud;
Digue, Laurence;
Guigay, Joël;
Cupissol, Didier;
Delord, Jean‐Pierre;
Lallemant, Benjamin;
Alfonsi, Marc;
Aubry, Karine;
Mazel, Martine;
Becher, François;
Perriard, Françoise;
Chatelut, Etienne;
Thomas, Fabienne

Publication type:

Article

Methadone dosing strategies in preterm neonates can be simplified.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1348, doi. 10.1111/bcp.13906

By:

Donge, Tamara;
Samiee‐Zafarghandy, Samira;
Pfister, Marc;
Koch, Gilbert;
Kalani, Majid;
Bordbar, Arash;
Anker, John

Publication type:

Article

Predicting the dose of vancomycin in ICU patients receiving different types of RRT therapy: a model‐based meta‐analytic approach.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1215, doi. 10.1111/bcp.13904

By:

Claisse, Guillaume;
Zufferey, Paul J.;
Trone, Jane C.;
Maillard, Nicolas;
Delavenne, Xavier;
Laporte, Silvy;
Ollier, Edouard

Publication type:

Article

Effects of dapagliflozin vs vildagliptin on cardiometabolic parameters in diabetic patients with coronary artery disease: a randomised study.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1337, doi. 10.1111/bcp.13903

By:

Phrommintikul, Arintaya;
Wongcharoen, Wanwarang;
Kumfu, Sirinart;
Jaiwongkam, Thidarat;
Gunaparn, Siriluck;
Chattipakorn, Siriporn;
Chattipakorn, Nipon

Publication type:

Article

Handling interoccasion variability in model‐based dose individualization using therapeutic drug monitoring data.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1326, doi. 10.1111/bcp.13901

By:

Abrantes, João A.;
Jönsson, Siv;
Karlsson, Mats O.;
Nielsen, Elisabet I.

Publication type:

Article

Bridging adults and paediatrics with secondary hyperparathyroidism receiving haemodialysis: a pharmacokinetic‐pharmacodynamic analysis of cinacalcet.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1312, doi. 10.1111/bcp.13900

By:

Chen, Ping;
Sohn, Winnie;
Narayanan, Adimoolam;
Gisleskog, Per Olsson;
Melhem, Murad

Publication type:

Article

Fluid volume kinetics of 20% albumin.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1303, doi. 10.1111/bcp.13897

By:

Hahn, Robert G.;
Zdolsek, Markus;
Hasselgren, Emma;
Zdolsek, Joachim;
Björne, Håkan

Publication type:

Article

Pharmacokinetics and pharmacodynamics of voxelotor (GBT440) in healthy adults and patients with sickle cell disease.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1290, doi. 10.1111/bcp.13896

By:

Hutchaleelaha, Athiwat;
Patel, Mira;
Washington, Carla;
Siu, Vincent;
Allen, Elizabeth;
Oksenberg, Donna;
Gretler, Daniel D.;
Mant, Timothy;
Lehrer‐Graiwer, Josh

Publication type:

Article

Cabozantinib‐related cardiotoxicity: a prospective analysis in a real‐world cohort of metastatic renal cell carcinoma patients.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1283, doi. 10.1111/bcp.13895

By:

Iacovelli, Roberto;
Ciccarese, Chiara;
Fornarini, Giuseppe;
Massari, Francesco;
Bimbatti, Davide;
Mosillo, Claudia;
Rebuzzi, Sara Elena;
Di Nunno, Vincenzo;
Grassi, Massimiliano;
Fantinel, Emanuela;
Ardizzoni, Andrea;
Tortora, Giampaolo

Publication type:

Article

Population/regional differences in efficacy of 3 drug categories (antidiabetic, respiratory and psychotropic agents) among East Asians: A retrospective study based on multiregional clinical trials.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1270, doi. 10.1111/bcp.13893

By:

Sai, Kimie;
Yoshida, Akiomi;
Hanatani, Tadaaki;
Imatoh, Takuya;
Takeuchi, Masahiro;
Narukawa, Mamoru;
Watanabe, Hiroshi;
Uyama, Yoshiaki;
Saito, Yoshiro

Publication type:

Article

Patterns of gabapentin and pregabalin use and misuse: Results of a population‐based cohort study in France.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1260, doi. 10.1111/bcp.13892

By:

Driot, Damien;
Jouanjus, Emilie;
Oustric, Stéphane;
Dupouy, Julie;
Lapeyre‐Mestre, Maryse

Publication type:

Article

Population pharmacokinetic–pharmacodynamic modelling of the relationship between testosterone and prostate specific antigen in patients with prostate cancer during treatment with leuprorelin.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1247, doi. 10.1111/bcp.13891

By:

Snelder, Nelleke;
Drenth, Henk‐Jan;
Riber Bergmann, Kirsten;
Wood, Nolan David;
Hibberd, Mark;
Scott, Graham

Publication type:

Article

Pharmacometrics and systems pharmacology for metabolic bone diseases.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1136, doi. 10.1111/bcp.13881

By:

Riggs, Matthew M.;
Cremers, Serge

Publication type:

Article

Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1072, doi. 10.1111/bcp.13869

By:

Stone, Julie A.;
McCrea, Jacqueline B.;
Witter, Rose;
Zajic, Stefan;
Stoch, S. Aubrey

Publication type:

Article

Pharmacology of bisphosphonates.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1052, doi. 10.1111/bcp.13867

By:

Cremers, Serge;
Drake, Matthew T.;
Ebetino, F. Hal;
Bilezikian, John P.;
Russell, R. Graham G.

Publication type:

Article

The skeletal impact of cancer therapies.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1161, doi. 10.1111/bcp.13866

By:

Bedatsova, Lucia;
Drake, Matthew T.

Publication type:

Article

Drugs for the treatment of metabolic bone diseases.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1049, doi. 10.1111/bcp.13857

By:

Drake, Matthew T.;
Cremers, Serge;
Russell, R. Graham;
Bilezikian, John P.

Publication type:

Article

Open‐label study to evaluate trifluridine/tipiracil safety, tolerability and pharmacokinetics in patients with advanced solid tumours and hepatic impairment.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1239, doi. 10.1111/bcp.13856

By:

Saif, Muhammad Wasif;
Rosen, Lee;
Rudek, Michelle A.;
Sun, Weijing;
Shepard, Dale R.;
Becerra, Carlos;
Yamashita, Fumiaki;
Bebeau, Paul;
Winkler, Robert

Publication type:

Article

Clinical and translational pharmacology of drugs for the prevention and treatment of bone metastases and cancer‐induced bone loss.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1114, doi. 10.1111/bcp.13852

By:

Dionísio, Maria Rita;
Mansinho, André;
Abreu, Catarina;
Cavaco‐Silva, Joana;
Casimiro, Sandra;
Costa, Luís

Publication type:

Article

Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1227, doi. 10.1111/bcp.13849

By:

Cohen, R.;
Preta, L. H.;
Joste, V.;
Curis, E.;
Huillard, O.;
Jouinot, A.;
Narjoz, C.;
Thomas‐Schoemann, A.;
Bellesoeur, A.;
Tiako Meyo, M.;
Quilichini, J.;
Desaulle, D.;
Nicolis, I.;
Cessot, A.;
Vidal, M.;
Goldwasser, F.;
Alexandre, J.;
Blanchet, B.

Publication type:

Article

Antiresorptive agents' bone‐protective and adjuvant effects in postmenopausal women with early breast cancer.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1125, doi. 10.1111/bcp.13834

By:

Chukir, Tariq;
Liu, Yi;
Farooki, Azeez

Publication type:

Article

Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1180, doi. 10.1111/bcp.13823

By:

Wentworth, Kelly L.;
Masharani, Umesh;
Hsiao, Edward C.

Publication type:

Article

Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1169, doi. 10.1111/bcp.13820

By:

Rotman, Marlous;
Hamdy, Neveen Agnes Therese;
Appelman‐Dijkstra, Natasha M.

Publication type:

Article

Genetic approaches to metabolic bone diseases.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1147, doi. 10.1111/bcp.13803

By:

Hannan, Fadil M.;
Newey, Paul J.;
Whyte, Michael P.;
Thakker, Rajesh V.

Publication type:

Article

Mechanisms that drive bone pain across the lifespan.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1103, doi. 10.1111/bcp.13801

By:

Mantyh, Patrick W.

Publication type:

Article

Restricting maintenance allopurinol dose according to kidney function in patients with gout is inappropriate!

Published in:

2019

By:

Stamp, Lisa K.;
Wright, Daniel F.B.;
Dalbeth, Nicola

Publication type:

Letter to the Editor

Regulatory aspects of the development of drugs for metabolic bone diseases – FDA and EMA perspective.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1208, doi. 10.1111/bcp.13791

By:

Kehoe, Theresa;
Blind, Eberhard;
Janssen, Heidi

Publication type:

Article

Special considerations for clinical trials in fibrodysplasia ossificans progressiva (FOP).

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1199, doi. 10.1111/bcp.13777

By:

Hsiao, Edward C.;
Di Rocco, Maja;
Cali, Amanda;
Zasloff, Michael;
Al Mukaddam, Mona;
Pignolo, Robert J.;
Grunwald, Zvi;
Netelenbos, Coen;
Keen, Richard;
Baujat, Genevieve;
Brown, Matthew A.;
Cho, Tae‐Joon;
De Cunto, Carmen;
Delai, Patricia;
Haga, Nobuhiko;
Morhart, Rolf;
Scott, Christiaan;
Zhang, Keqin;
Diecidue, Robert J.;
Friedman, Clive S.

Publication type:

Article

Update on pharmacologically‐relevant vitamin D analogues.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1095, doi. 10.1111/bcp.13781

By:

Jones, Glenville;
Kaufmann, Martin

Publication type:

Article

Osteoanabolic and dual action drugs.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1084, doi. 10.1111/bcp.13766

By:

Tabacco, Gaia;
Bilezikian, John P.

Publication type:

Article

Pharmacological management of X‐linked hypophosphataemia.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1188, doi. 10.1111/bcp.13763

By:

Imel, Erik A.;
White, Kenneth E.

Publication type:

Article

Side effects of drugs for osteoporosis and metastatic bone disease.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1063, doi. 10.1111/bcp.13759

By:

Skjødt, Michael Kriegbaum;
Frost, Morten;
Abrahamsen, Bo

Publication type:

Article

Issue Information.

Published in:: British Journal of Clinical Pharmacology, 2019, v. 85, n. 6, p. 1045, doi. 10.1111/bcp.13680
Publication type:: Article